Article info
PDFLetter
Anti-tumour necrosis factor monoclonal antibody treatment for ocular Behçet's disease
- Correspondence to:
Professor G Triolo, Rheumatology and Clinical Immunology Unit, Istituto di Clinica Medica, Policlinico Universitario, Piazza delle Cliniche 2, 90127 Palermo, Italy;
triolog{at}tiscalinet.it
Citation
Anti-tumour necrosis factor monoclonal antibody treatment for ocular Behçet's disease
Publication history
- Accepted November 7, 2001
- First published June 1, 2002.
Online issue publication
April 13, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2002 by Annals of the Rheumatic Diseases